For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Gooderham’s sessions covered upcoming AD drug approvals, patient satisfaction and QoL improvement, and RAD 2023 takeaways.
Answers to some common questions about providing telehealth services in 2023.
Ablon presented sessions on nutrition, exosome therapy, and treating the hair-challenged patient at SCALE 2023.
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
A key session at the annual meeting will share practical advice and tools to better support you and your patients.
Tips on growing your practice.
Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
An expert in dermatology reviews the differences in Isotretinoin and highlights how this treatment is both highly efficacious and safe when administered and monitored properly.
The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
In this month's financial planning column, the OJM group talks about volatile markets and how to navigate investing in uncertain times.
Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.
The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.
The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.
Collins said an office environment impacts outcomes and shared office design considerations.
Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.
Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.
A look at the common condition and how to treat it.
Pandya gives an in-depth overview of his vitiligo treatment pearls from the 2023 Pigmentary Disorders Exchange Symposium.
Raj Chovatiya, MD, PhD, discusses highlights from his sessions at RAD 2023 on best practices for AD management.
A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.
Fresh spins on established treatments and newly FDA-approved drugs and devices provide a framework for changing therapies and modalities for acne regimens.